These sounds can be used as a comparison tool for practitioners. Following patient auscultation in the clinical setting, practitioners can listen to the heart sounds below to help identify those encountered in practice.
These recordings, taken with an electronic stethoscope on actual patients, may include some background noise. The sounds have not been modified; headphones are recommended for optimal listening. Unless specified, all sounds are from canine patients.
Compounding is the reformulation of an active pharmaceutical ingredient into a customized medicine specific to the needs of an individual animal. In this article, see how compounded medications measure up against Vetmedin® (pimobendan) Chewable Tablets for patients with congestive heart failure.
Accurately staging patients with myxomatous mitral valve disease is critical to ensuring appropriate treatment to help achieve the best possible outcome for these patients. in this article, get tips for how to properly stage these patients.
MMVD is the most common heart disease of dogs in many parts of the world, accounting for ≈75% of heart disease cases in dogs in North America. Explore this infographic from the most recent consensus guidelines from ACVIM to better diagnose and treat these patients.
Vertebral left atrial size (VLAS) is an objective radiographic measurement that can help determine whether left atrial enlargement is present with suspected or diagnosed myxomatous mitral valve disease. Review how to calculate VLAS in dogs.
Vertebral heart score is useful when evaluating dogs for cardiomegaly, but different breeds may have different reference limits. Review this study that evaluated these measurements in Chihuahuas.